Related Experiment Video
Updated: Aug 2, 2026
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Drug Resistance
1Department of Oncology, Free University Hospital, HV 1081 Amsterdam, The Netherlands.
Abstract:
Chemotherapy fails to cure most cancer patients with advanced disease, particularly patients with the most common forms of solid tumors. The presence or development of resistance to anticancer agents is the major cause of this failure. Several of the mechanisms underlying drug resistance to cytotoxic drugs have been elucidated in the last two decades, largely by employing in vitro drug-selected cancer cell lines. In unselected cell lines and probably also in human cancer, multiple mechanisms are redundantly present to defend the organism from the insults of drugs. Mechanisms have been unraveled by which cross-resistance ensues to multiple drugs (multidrug resistance), similar to what is commonly seen in patients. More recently, the identification of downstream genes, intimately involved in cell-cycle checkpoints, appears also to directly contribute to determining the sensitivity to cytotoxic drugs by regulating the response of the cell to the drug damage. The identification of mechanisms of drug resistance has provided ways of attempting to revert the drug resistance. Although, so far, attempts to revert P-glycoprotein-mediated multidrug resistance have only sorted out limited efficacy, new drugs and new strategies are being devised and implemented, such as high-dose chemotherapy and gene transfer.
Insights
Cancer drug resistance is a major hurdle in treating advanced solid tumors. Understanding resistance mechanisms is key to developing new therapies and improving patient outcomes.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Chemotherapy is often ineffective for advanced cancers, primarily due to drug resistance.
- Drug resistance in cancer cells, including multidrug resistance, is a complex phenomenon.
- Multiple redundant mechanisms contribute to cellular defense against cytotoxic drugs.
Purpose of the Study:
- To elucidate the mechanisms underlying anticancer drug resistance.
- To understand how multiple resistance mechanisms develop and lead to multidrug resistance.
- To identify novel strategies for overcoming drug resistance in cancer treatment.
Main Methods:
- Utilized in vitro drug-selected cancer cell lines to study resistance mechanisms.
- Investigated the role of downstream genes involved in cell-cycle checkpoints.
- Analyzed mechanisms of cross-resistance leading to multidrug resistance.
Main Results:
- Identified multiple, redundant mechanisms contributing to drug resistance in cancer cells.
- Elucidated pathways leading to cross-resistance and multidrug resistance.
- Demonstrated the involvement of cell-cycle checkpoint genes in drug sensitivity.
Conclusions:
- Understanding drug resistance mechanisms is crucial for improving chemotherapy efficacy.
- New therapeutic strategies, including gene transfer and high-dose chemotherapy, are being explored.
- Targeting resistance pathways offers potential for overcoming treatment failure in advanced cancers.
More Related Videos
09:58Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
Related Concept Videos
00:57Antibiotic Selection
02:56Treatment Resistant Cancers
02:56Treatment Resistent Cancers
01:30Development of Antibiotic Resistance
01:25Mechanism of Antibiotic Resistance in MRSA
01:25Clinical Significance of Antibiotic Resistance